<SEC-DOCUMENT>0001193125-24-225162.txt : 20241025
<SEC-HEADER>0001193125-24-225162.hdr.sgml : 20241025
<ACCEPTANCE-DATETIME>20240925060856
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-24-225162
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240925

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioAge Labs, Inc.
		CENTRAL INDEX KEY:			0001709941
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				474721157
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		1445A SOUTH 50TH STREET
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
		BUSINESS PHONE:		510-806-1445

	MAIL ADDRESS:	
		STREET 1:		1445A SOUTH 50TH STREET
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g835745g0925001331575.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;25, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>VIA EDGAR AND ELECTRONIC TRANSMISSION</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S.
Securities and Exchange Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Office of Life Sciences </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street, NE </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, DC 20549 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">Attention:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Eric Atallah </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Vanessa Robertson </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Jimmy McNamara
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Joshua Gorsky </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>BioAge</B><B> Labs Inc.</B> <B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>Amendment No.</B><B></B><B>&nbsp;1 to Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT></B> <B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>Filed September</B><B></B><B>&nbsp;18, 2024</B> <B><U> </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B><U>File No.</U></B><B><U></U></B><B><U><FONT STYLE="white-space:nowrap">&nbsp;333-281901</FONT></U></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are submitting this
letter on behalf of BioAge Labs, Inc. (the &#147;<B><I>Company</I></B>&#148;) in response to the comment of the staff (the &#147;<B><I>Staff</I></B>&#148;) of the U.S. Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;)
contained in the Staff&#146;s letter dated September&nbsp;23, 2024 (the &#147;<B><I>Letter</I></B>&#148;), regarding the Company&#146;s Amendment No.&nbsp;1 to the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> (File <FONT
STYLE="white-space:nowrap">No.&nbsp;333-281901)</FONT> filed by the Company with the Commission on September&nbsp;18, 2024 (the &#147;<B><I>Registration Statement</I></B>&#148;). Concurrently, we are transmitting herewith and filing a copy of the
Company&#146;s Amendment No.&nbsp;2 to the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> (&#147;<B><I>Amendment No.</I></B><B><I></I></B><B><I>&nbsp;2</I></B>&#148;). The numbered paragraph below corresponds to the
numbered comment in the Letter and the Staff&#146;s comment is presented in bold italics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to addressing the comment raised by
the Staff in the Letter, the Company has revised Amendment No.&nbsp;2 to update certain other disclosures. Capitalized terms used and not otherwise defined herein have the same meanings as specified in the Amendment No.&nbsp;2. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;25, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page&nbsp;2 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Amendment No.&nbsp;1 to Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Notes to Condensed Consolidated Financial Statements </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Note 12. Subsequent Events, page <FONT STYLE="white-space:nowrap">F-50</FONT> </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><B><I>1.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Please disclose the number of options that have been issued subsequent to June&nbsp;30, 2024 and the
estimated fair value of the underlying common stock.</I></B><B> </B></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In response to the Staff&#146;s comment, the
Company has revised its disclosure beginning on page <FONT STYLE="white-space:nowrap">F-50</FONT> of Amendment No.&nbsp;2 to disclose the number of options that have been issued subsequent to June&nbsp;30, 2024 and the estimated fair value of the
underlying common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>* * * * * * * </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should the Staff have additional questions or comments regarding the foregoing, please do not hesitate to contact me at (415) <FONT
STYLE="white-space:nowrap">875-2420,</FONT> or in my absence, Robert Freedman at (206) <FONT STYLE="white-space:nowrap">389-4524.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Julia Forbess</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Julia Forbess</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FENWICK&nbsp;&amp; WEST LLP</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">cc: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kristen Fortney,
Chief Executive Officer and President </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BioAge Labs, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert Freedman, Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Matthew Rossiter, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael Pilo, Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fenwick&nbsp;&amp; West LLP </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charlie S. Kim, Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Denny Won, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Divakar Gupta, Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cooley LLP </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g835745g0925001331575.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g835745g0925001331575.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !1 FX# 2(  A$! Q$!_\0
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MRK &@($8"'!/?/-<FNH2:=I>J:.X.Z20#Z8//YBNI%I]D^&,@(PTJ>8?Q/\
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M!FZ59S6;7".6,3,K)N<MSM&[K[YK2HHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (#96S3&8P1F0C!
M8KR:2*QM83F."-3TX6K%% #!#&NS"*/+&$X^[]*CDL[:48D@C8;MW*]_6IZ*
M (!9VRQA! @09P-O'3%-_L^S\KROLT>S&,;:LT4 5_L-KO5_L\>Y5V@[>@H2
MQM8C&8X5382R[1C!-6** ('L[:6;S7@C:0#&XKS4@AB!0B-1L&%XZ4^B@"*.
MV@A9VCB1&?EB!UH^S08 \I, %0,=CUJ6B@")+:".'R4B18_[H'%2T44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 )1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
